NO972620L - RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon - Google Patents
RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjonInfo
- Publication number
- NO972620L NO972620L NO972620A NO972620A NO972620L NO 972620 L NO972620 L NO 972620L NO 972620 A NO972620 A NO 972620A NO 972620 A NO972620 A NO 972620A NO 972620 L NO972620 L NO 972620L
- Authority
- NO
- Norway
- Prior art keywords
- inflammation
- fragments
- mixtures
- treatment
- rantes peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9424835.8A GB9424835D0 (en) | 1994-12-08 | 1994-12-08 | Substances and their uses |
GBGB9512319.6A GB9512319D0 (en) | 1995-06-16 | 1995-06-16 | Substances and their uses |
PCT/GB1995/002861 WO1996017935A2 (en) | 1994-12-08 | 1995-12-07 | Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972620D0 NO972620D0 (no) | 1997-06-06 |
NO972620L true NO972620L (no) | 1997-08-06 |
Family
ID=26306133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972620A NO972620L (no) | 1994-12-08 | 1997-06-06 | RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon |
Country Status (15)
Country | Link |
---|---|
US (2) | US6159711A (es) |
EP (1) | EP0796330A1 (es) |
JP (1) | JPH10510151A (es) |
CN (1) | CN1087346C (es) |
AU (1) | AU688641B2 (es) |
BR (1) | BR9509890A (es) |
CA (1) | CA2207036A1 (es) |
CZ (1) | CZ290850B6 (es) |
FI (1) | FI972433A (es) |
HU (1) | HU221089B1 (es) |
MX (1) | MX9703889A (es) |
NO (1) | NO972620L (es) |
NZ (1) | NZ296570A (es) |
PL (1) | PL182786B1 (es) |
WO (1) | WO1996017935A2 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10510151A (ja) * | 1994-12-08 | 1998-10-06 | グラクソ、グループ、リミテッド | Rantesペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物 |
FR2748938B1 (fr) * | 1996-05-22 | 1998-07-31 | Pasteur Institut | Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih |
EP0972043A1 (en) * | 1996-09-25 | 2000-01-19 | British Biotech Pharmaceuticals Limited | Human rantes mutants incapable of aggregate formation |
US6100387A (en) * | 1997-02-28 | 2000-08-08 | Genetics Institute, Inc. | Chimeric polypeptides containing chemokine domains |
US6852508B1 (en) | 1997-02-28 | 2005-02-08 | Genetics Institute, Llc | Chemokine with amino-terminal modifications |
IT1291353B1 (it) * | 1997-05-12 | 1999-01-07 | San Raffaele Centro Fond | Peptidi con attivita' antivirale |
US6168784B1 (en) | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
EP0906954A1 (en) * | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | Amino-terminal truncated c-c chemokines as chemokine antagonist |
MXPA00003885A (es) * | 1997-10-22 | 2004-04-23 | Inst Genetics Llc | Quimiocinas con modificiaciones de la terminacion amino. |
ES2247475T3 (es) * | 1997-12-23 | 2006-03-01 | Fondazione Centro San Raffaele Del Monte Tabor | Mutantes de rantes y sus aplicaciones terapeuticas. |
US6121023A (en) * | 1998-01-22 | 2000-09-19 | Akzo Nobel N.V. | Isothermal transcription based assay for the detection and quantification of the chemokine rantes |
EP1000626A1 (en) * | 1998-09-18 | 2000-05-17 | Applied Research Systems ARS Holding N.V. | Chemokine receptor antagonist and cyclosporin in combined therapy |
IT1303736B1 (it) * | 1998-11-11 | 2001-02-23 | San Raffaele Centro Fond | Peptidi derivati da rantes con attivita' anti-hiv. |
AU3269399A (en) * | 1999-03-22 | 2000-10-09 | Universitat Zurich | Transforming growth factor (tfg) beta superfamily antagonists |
KR20030046411A (ko) | 2000-09-08 | 2003-06-12 | 그리폰 테라퓨틱스, 인코포레이티드 | '위'-천연 화학적 라이게이션 |
US7998681B2 (en) * | 2000-10-06 | 2011-08-16 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders |
US8153121B2 (en) * | 2000-10-06 | 2012-04-10 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
IL161441A0 (en) * | 2001-10-30 | 2004-09-27 | Harvard College | Pathway of rantes-mediated chemokine synthesis in astrocytes and method of use therefor |
WO2003051921A1 (en) * | 2001-12-17 | 2003-06-26 | Applied Research Systems Ars Holding N.V. | Chemokine mutants acting as chemokine antagonists |
US20040191215A1 (en) * | 2003-03-25 | 2004-09-30 | Michael Froix | Compositions for induction of a therapeutic response |
US7390788B2 (en) * | 2005-06-23 | 2008-06-24 | Pert Candace B | Peptide pharmaceutical compositions |
WO2008015199A1 (en) * | 2006-07-31 | 2008-02-07 | Laboratoires Serono S.A. | Chemokine antagonists |
CN101802211B (zh) * | 2007-08-02 | 2014-10-01 | 诺维莫尼公司 | 抗正常t细胞表达和分泌活化调节因子(rantes)抗体及其使用方法 |
CA2788902C (en) * | 2010-02-08 | 2019-09-03 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
WO2013024022A1 (en) | 2011-08-12 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
WO2023057589A1 (en) | 2021-10-06 | 2023-04-13 | Virothera Ltd | Novel immune regulator |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10510151A (ja) * | 1994-12-08 | 1998-10-06 | グラクソ、グループ、リミテッド | Rantesペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物 |
-
1995
- 1995-12-07 JP JP8517418A patent/JPH10510151A/ja not_active Abandoned
- 1995-12-07 CZ CZ19971719A patent/CZ290850B6/cs not_active IP Right Cessation
- 1995-12-07 BR BR9509890A patent/BR9509890A/pt not_active Application Discontinuation
- 1995-12-07 HU HU9702199A patent/HU221089B1/hu not_active IP Right Cessation
- 1995-12-07 EP EP95939348A patent/EP0796330A1/en not_active Withdrawn
- 1995-12-07 US US08/836,922 patent/US6159711A/en not_active Expired - Fee Related
- 1995-12-07 PL PL95320565A patent/PL182786B1/pl not_active IP Right Cessation
- 1995-12-07 WO PCT/GB1995/002861 patent/WO1996017935A2/en not_active Application Discontinuation
- 1995-12-07 AU AU41208/96A patent/AU688641B2/en not_active Ceased
- 1995-12-07 CN CN95196640A patent/CN1087346C/zh not_active Expired - Fee Related
- 1995-12-07 NZ NZ296570A patent/NZ296570A/en unknown
- 1995-12-07 CA CA002207036A patent/CA2207036A1/en not_active Abandoned
- 1995-12-07 MX MX9703889A patent/MX9703889A/es unknown
-
1997
- 1997-06-06 NO NO972620A patent/NO972620L/no not_active Application Discontinuation
- 1997-06-06 FI FI972433A patent/FI972433A/fi not_active IP Right Cessation
-
2000
- 2000-08-17 US US09/639,881 patent/US6555105B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO972620D0 (no) | 1997-06-06 |
CZ171997A3 (en) | 1997-11-12 |
FI972433A0 (fi) | 1997-06-06 |
US6159711A (en) | 2000-12-12 |
CA2207036A1 (en) | 1996-06-13 |
PL320565A1 (en) | 1997-10-13 |
EP0796330A1 (en) | 1997-09-24 |
BR9509890A (pt) | 1997-12-30 |
AU688641B2 (en) | 1998-03-12 |
CN1168697A (zh) | 1997-12-24 |
AU4120896A (en) | 1996-06-26 |
JPH10510151A (ja) | 1998-10-06 |
WO1996017935A2 (en) | 1996-06-13 |
HU221089B1 (en) | 2002-08-28 |
NZ296570A (en) | 1998-11-25 |
CN1087346C (zh) | 2002-07-10 |
PL182786B1 (pl) | 2002-02-28 |
US6555105B1 (en) | 2003-04-29 |
HUT77075A (hu) | 1998-03-02 |
MX9703889A (es) | 1997-08-30 |
WO1996017935A3 (en) | 1996-08-22 |
FI972433A (fi) | 1997-06-06 |
CZ290850B6 (cs) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO972620L (no) | RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon | |
NO307408B1 (no) | Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev | |
GB9617021D0 (en) | Novel peptides for treatment of inflammation and shock | |
NO994778D0 (no) | FremgangsmÕter og sammensetninger for behandling av tarmbetennelse | |
HUP9901109A3 (en) | Peptide immunogens for vaccination against and treatment of allergy | |
IS5157A (is) | Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma | |
NO944853D0 (no) | Glukagonlignende peptid og insulinotropinderivater | |
NO972125D0 (no) | Hemmoroideblandinger og fremgangsmåte for anvendelse | |
NO971015L (no) | Forbindelser og metoder for behandling av cancer | |
IL125446A0 (en) | Pharmaceutical composition for the treatment of asthma allergy and inflammation | |
DK64592D0 (da) | Peptider til terapeutisk behandling | |
AU5684594A (en) | Novel human amyloid protein precursor homologue and kunitz-type inhibitors | |
NO971900D0 (no) | Blandinger og behandling av multippel sklerose | |
NO982727D0 (no) | PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon | |
DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
NO982100D0 (no) | Peptid-derivater av Dolastatin 15 og deres anvendelse | |
IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
NO964330D0 (no) | Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav | |
DE69418931D1 (de) | Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten | |
HK1044468A1 (zh) | 治療哮喘和炎症的小肽和方法 | |
BR9407197A (pt) | Composição farmacêutica pra tratamento imunomodulador e adjuvante | |
IL112681A0 (en) | Opioid peptides for the treatment of pain and use thereof | |
IL105186A0 (en) | Partially modified and retroinverted tetrapeptide analogues of c-reactive protein fragments | |
DE69501944D1 (de) | Arzneimittel zur Vorbeugung oder Behandlung von chronischem Rheumatismus und Sepsis | |
NO952194D0 (no) | Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |